Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.

Philippe Soriano

Genes & Development · 1994 · 990 citations · 39 references

DOIFull text

Open access

Concepts

TL;DR

Platelet‑derived growth factor is a major mitogen and chemoattractant involved in wound healing, tumorigenesis, and differentiation, acting through alpha and beta receptors. The study aims to understand the role of PDGF beta‑receptors in development by generating beta‑receptor‑deficient mice. Beta‑receptor‑deficient mice were created via gene targeting in embryonic stem cells. Mutant mice are hemorrhagic, thrombocytopenic, and severely anemic, exhibit a defect in kidney glomeruli due to lack of mesangial cells, and die at or shortly before birth, yet many tissues expressing the receptor appear normal, indicating that the beta receptor is essential in certain cell types during embryonic development but its broader role may be masked by compensation from the alpha‑subunit.

Abstract

Platelet-derived growth factor, a major mitogen and chemoattractant for a number of cell types, is implicated in the processes of wound healing, tumorigenesis, and differentiation and is recognized by two receptors, alpha and beta. To begin understanding the role of these receptors in development, beta-receptor-deficient mice were generated by gene targeting in ES cells. Mutant mice are hemorrhagic, thrombocytopenic, and severely anemic, exhibit a defect in kidney glomeruli because of a lack of mesangial cells, and die at or shortly before birth. However, many cell types and tissues that express the receptor, including major blood vessels and the heart, appear normal in the absence of the receptor. These results indicate that whereas the beta receptor is essential in certain cell types during embryonic development, its broader role may be masked because of compensation by the alpha-subunit.

References

39